Plasma is named as an intervention in 3 current clinical trials in our USA, Canada and Israel registers. 2 are recruiting patients now. The most common phase is Phase 1. The sponsor with the most trials is Vitruvian Medical Devices, Inc (1). The most-studied condition is Foot Ulcer, Diabetic.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients
NCT07094724 · ClinicalTrials.gov ↗ · West Nile Fever
|
Phase 2 | Recruiting | Gili Regev-Yochay MD | Israel |
|
SWiFT Canada (Study of Whole Blood in Frontline Trauma)
NCT06495294 · ClinicalTrials.gov ↗ · Trauma
|
Not applicable | Recruiting | Unity Health Toronto | Canada |
|
Study to Assess the Safety of DERMASEAL for Diabetic Foot Ulcers
NCT05586542 · Foot Ulcer, Diabetic
|
Phase 1 | Active, closed | Vitruvian Medical Devices, Inc | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Vitruvian Medical Devices, Inc | 1 |
| Unity Health Toronto | 1 |
| Gili Regev-Yochay MD | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 1 | 0 |
| Clinical trials in Canada | 1 | 1 |
| Clinical trials in Israel | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
3 current trials in our USA, Canada and Israel registers name Plasma as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 3 trials are recruiting: 1 with sites in Canada and 1 with sites in Israel. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Vitruvian Medical Devices, Inc (1), Unity Health Toronto (1) and Gili Regev-Yochay MD (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Plasma works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Plasma works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Plasma (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.